X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
adiponectin - blood (1) 1
advanced glycation end product (1) 1
age (1) 1
age factors (1) 1
aged (1) 1
albuminuria (1) 1
albuminuria - drug therapy (1) 1
all-cause mortality (1) 1
chelating agents - therapeutic use (1) 1
cystatin c (1) 1
diabetes mellitus, type 2 - blood (1) 1
diabetes mellitus, type 2 - complications (1) 1
diabetes mellitus, type 2 - drug therapy (1) 1
diabetic nephropathies - blood (1) 1
diabetic nephropathies - drug therapy (1) 1
diabetic nephropathy (1) 1
dinoprost - analogs & derivatives (1) 1
dinoprost - blood (1) 1
estrogen receptor alpha - blood (1) 1
ethnicity (1) 1
european continental ancestry group (1) 1
female (1) 1
glomerular-filtration-rate (1) 1
glycated hemoglobin a - metabolism (1) 1
glycation end products, advanced - blood (1) 1
humans (1) 1
hypoglycemic agents - therapeutic use (1) 1
index medicus (1) 1
insulin-resistance (1) 1
intention to treat analysis (1) 1
lysine - analogs & derivatives (1) 1
lysine - blood (1) 1
male (1) 1
metformin - therapeutic use (1) 1
middle aged (1) 1
nephropathy (1) 1
nf-e2-related factor 2 - blood (1) 1
nf-e2-related factor 2 - genetics (1) 1
original (1) 1
original articles (1) 1
oxidative stress (1) 1
paradigm shift (1) 1
pyruvaldehyde - blood (1) 1
receptor for advanced glycation end products - blood (1) 1
receptor for advanced glycation end products - genetics (1) 1
receptors, tumor necrosis factor, type i - blood (1) 1
receptors, tumor necrosis factor, type i - genetics (1) 1
risk (1) 1
rna, messenger - blood (1) 1
sevelamer - therapeutic use (1) 1
sex factors (1) 1
single-blind method (1) 1
sirtuin 1 - blood (1) 1
sirtuin 1 - genetics (1) 1
tnf receptors 1 (1) 1
urology & nephrology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 01/2015, Volume 10, Issue 5, pp. 759 - 766
Background and objectives The primary goals were to re-examine whether sevelamer carbonate (SC) reduces advanced glycation end products (AGEs) (methylglyoxal... 
ALL-CAUSE MORTALITY | GLOMERULAR-FILTRATION-RATE | ALBUMINURIA | INSULIN-RESISTANCE | UROLOGY & NEPHROLOGY | RISK | NEPHROPATHY | TNF RECEPTORS 1 | PARADIGM SHIFT | CYSTATIN C | AGE | Single-Blind Method | Dinoprost - blood | Metformin - therapeutic use | Age Factors | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Diabetic Nephropathies - drug therapy | Male | Diabetic Nephropathies - blood | Sirtuin 1 - genetics | Sevelamer - therapeutic use | Female | NF-E2-Related Factor 2 - genetics | Dinoprost - analogs & derivatives | Receptor for Advanced Glycation End Products - genetics | Chelating Agents - therapeutic use | Diabetes Mellitus, Type 2 - complications | Lysine - blood | NF-E2-Related Factor 2 - blood | Receptor for Advanced Glycation End Products - blood | Hypoglycemic Agents - therapeutic use | Lysine - analogs & derivatives | Receptors, Tumor Necrosis Factor, Type I - blood | European Continental Ancestry Group | Receptors, Tumor Necrosis Factor, Type I - genetics | Sirtuin 1 - blood | Adiponectin - blood | Diabetes Mellitus, Type 2 - blood | RNA, Messenger - blood | Albuminuria - drug therapy | Intention to Treat Analysis | Sex Factors | Estrogen Receptor alpha - blood | Glycation End Products, Advanced - blood | Aged | Diabetes Mellitus, Type 2 - drug therapy | Pyruvaldehyde - blood | advanced glycation end product | albuminuria | ethnicity | Original | diabetic nephropathy | oxidative stress
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.